Atezolizumab
id:
atezolizumab-179-9057174
title:
Atezolizumab
text:
Atezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma, but discontinued for use in triple-negative breast cancer (TNBC). It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). The most common side effects when used on
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal anti-PD-L1 antibody
original url:
https://en.wikipedia.org/wiki/Atezolizumab
date created:
2015-06-01T22:27:05Z
date modified:
2024-09-05T01:28:01Z
main entity:
{"identifier":"Q20707748","url":"https://www.wikidata.org/entity/Q20707748"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e6/Atezolizumab_PD-L1_5X8L.png","width":2048,"height":2048}
fields total:
13
integrity:
16